We are live on
!
Find out more
LDNAM
Lepercq De Neuflize Asset Management Portfolio holdings
AUM
$138M
1-Year Est. Return
15.9%
This Fund
S&P 500
This Quarter
Est. Return
+0.11%
1 Year Est. Return
+15.9%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$36.2M
(-26%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-34.7%
Top 10 Holdings %
Top 10 Hldgs %
99.92%
Holding
16
New
2
Increased
3
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AN2 Therapeutics
ANTX
|
+$29.2K |
| 2 |
LVTX
LAVA Therapeutics
LVTX
|
+$25.6K |
| 3 |
ENZ
Enzo Biochem, Inc.
ENZ
|
+$18.4K |
| 4 |
Clarus
CLAR
|
+$5.38K |
| 5 |
EPIX
ESSA Pharma
EPIX
|
+$2.54K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$23.7M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$12.3M |
| 3 |
Lifecore Biomedical
LFCR
|
+$18.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.42% |
| 2 | Technology | 0.12% |
| 3 | Consumer Discretionary | 0.08% |
| 4 | Real Estate | 0.07% |
| 5 | Energy | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $64.5M | 62.41% |
115,245
| – | – |
|
2
iShares MSCI EAFE ETF
EFA
$77B
| $38.1M | 36.87% |
466,000
| – | – |
|
|
3
Lifecore Biomedical
LFCR
$168M
| $139K | 0.13% |
19,700
-3,000
| -13% | -$18.6K |
|
|
XYLO
4
DELISTED
Xylo Technologies
XYLO
| $128K | 0.12% |
26,059
| – | – |
|
5
Wetouch Technology
WETH
$15.4M
| $98.5K | 0.1% |
67,954
| – | – |
|
|
6
Clarus
CLAR
$125M
| $83.3K | 0.08% |
22,200
+1,200
| +6% | +$5.38K |
|
7
Presidio Property Trust
SQFT
$3.01M
| $77.1K | 0.07% |
13,413
| – | – |
|
|
ENZ
8
DELISTED
Enzo Biochem, Inc.
ENZ
| $57.8K | 0.06% |
156,303
+33,303
| +27% | +$18.4K |
|
|
EPIX
9
DELISTED
ESSA Pharma
EPIX
| $50.1K | 0.05% |
31,700
+1,500
| +5% | +$2.54K |
|
|
10
AN2 Therapeutics
ANTX
$175M
| $31.6K | 0.03% |
+23,234
| New | +$29.2K |
|
|
LVTX
11
DELISTED
LAVA Therapeutics
LVTX
| $29.2K | 0.03% |
+23,000
| New | +$25.6K |
|
12
Barnwell Industries
BRN
$14.3M
| $24.3K | 0.02% |
15,000
| – | – |
|
13
Deswell Industries
DSWL
$54.5M
| $23.6K | 0.02% |
10,000
| – | – |
|
|
LGL.WS
14
DELISTED
LGL Group Inc Warrants
LGL.WS
| $8.38K | 0.01% |
26,200
| – | – |
|
|
15
iShares MSCI ACWI ETF
ACWI
$32.5B
| – | – |
-104,300
| Closed | -$12.3M |
|
|
16
Invesco QQQ Trust
QQQ
$446B
| – | – |
-46,278
| Closed | -$23.7M |
|
Similar funds
RC
PF
FP
DW
TC
PBRA
DFS
LPAM
Lepercq De Neuflize Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Lepercq De Neuflize Asset Management held 16 positions worth $103M, down 26% from $139M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lepercq De Neuflize Asset Management withdrew a net $35.9M in Q1 2025, closing 2 positions and reducing 1 holding. Its most notable exit was Invesco QQQ Trust, an estimated $23.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0.42% of assets, up from 0.29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Lepercq De Neuflize Asset Management opened a new position in AN2 Therapeutics worth $31.6K.
- Lepercq De Neuflize Asset Management's largest Q1 2025 buy was AN2 Therapeutics: 23,234 shares worth $31.6K.
- Lepercq De Neuflize Asset Management added most to Enzo Biochem, Inc. in Q1 2025, an estimated $18.4K increase.
- Lepercq De Neuflize Asset Management's biggest Q1 2025 reduction was Lifecore Biomedical, cutting an estimated $18.6K.
- Lepercq De Neuflize Asset Management fully exited Invesco QQQ Trust in Q1 2025, selling an estimated $23.7M.
- Lepercq De Neuflize Asset Management's ten largest holdings make up 100% of its $103M portfolio in Q1 2025.
- Lepercq De Neuflize Asset Management opened 2 new positions and closed 2 in Q1 2025.
- Lepercq De Neuflize Asset Management's portfolio value fell 26% quarter-over-quarter to $103M.
Based on Lepercq De Neuflize Asset Management's 13F filing for Q1 2025, filed 13 May 2025.